The merger with CompliMed means that PharmaLex will provide even greater support to its clients in their commitment to responsible and ethical promotion and practices
Frankfurt, Germany – 7th January 2020: PharmaLex Group, one of the most experienced and most successful specialist providers of Development Consulting, Regulatory Affairs, Pharmacovigilance, Epidemiology & Risk Management, and Quality Management & Compliance worldwide, have completed the merger with CompliMed in the United Kingdom.
CompliMed is the UK’s leading Healthcare Compliance Consultancy specialising in the ABPI Code of Practice. Their services include training, e-learning, outsourcing, audits, SOPs, medical review and final signatory support.
By joining forces with CompliMed, PharmaLex will extend its services in healthcare compliance, further enabling its customers to maximise promotional effectiveness whilst complying with legislation and codes of practice during their engagements with healthcare professionals, the public and patients. This will provide a strategic fit where PharmaLex already acts as medical reviewer, Information Officer or certifying signatory in line with national requirements in European countries.
“The merger with PharmaLex is a major milestone for CompliMed”, explained Dr. Rina Newton, Managing Director, CompliMed. “We are excited to be able to strengthen the services they offer as we become part of a larger organization with an excellent reputation and significant global footprint”, she added.
“CompliMed are a perfect fit for PharmaLex”, explained Dr Thomas Dobmeyer, CEO PharmaLex. “Our strategy is to build a European service line that offers healthcare compliance in all European countries and the US. CompliMed are trusted by their customers for their high-quality standards. Having such a dependable team join PharmaLex is a real asset as both organisations are committed to outstanding service levels and delivering exceptional client solutions”, he added.
About PharmaLex <Confidence beyond compliance>:
PharmaLex is one of the largest providers of specialist services for Development Consulting, Regulatory Affairs, Quality Management & Compliance and Pharmacovigilance, Epidemiology and Risk Management worldwide. Our global teams of experts can take you through early strategic planning activities and non-clinical requirements to clinical development, through regulatory submission processes and finally guide you to market approval and product maintenance post-launch activities. We strive to deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions. We aim to exceed your expectations and live by our values – flexibility, efficiency, passion and dedication.
The PharmaLex Group now has over 1000 employees, with 32 offices in 17 countries and more than 600 satisfied clients worldwide.
For further information, please contact:
Ms. Eva Keck
PharmaLex GmbH; Director, Business Development Operations
+49 621 18 15 38 0